Global Hemophilia A Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Hemophilia A Drug

• 1.1 Definition of Hemophilia A Drug
• 1.2 Hemophilia A Drug Segment by Type
  • 1.2.1 Global Hemophilia A Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ATXF-8117
  • 1.2.3 BAY-1093884
  • 1.2.4 BIVV-001
  • 1.2.5 BS-027125
  • 1.2.6 Concizumab
  • 1.2.7 CSL-689
  • 1.2.8 Others
• 1.3 Hemophilia A Drug Segment by Applications
  • 1.3.1 Global Hemophilia A Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 ASCs
• 1.4 Global Hemophilia A Drug Overall Market
  • 1.4.1 Global Hemophilia A Drug Revenue (2014-2025)
  • 1.4.2 Global Hemophilia A Drug Production (2014-2025)
  • 1.4.3 North America Hemophilia A Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Hemophilia A Drug Status and Prospect (2014-2025)
  • 1.4.5 China Hemophilia A Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Hemophilia A Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Hemophilia A Drug Status and Prospect (2014-2025)
  • 1.4.8 India Hemophilia A Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Hemophilia A Drug
• 2.3 Manufacturing Process Analysis of Hemophilia A Drug
• 2.4 Industry Chain Structure of Hemophilia A Drug

3 Development and Manufacturing Plants Analysis of Hemophilia A Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Hemophilia A Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Hemophilia A Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Hemophilia A Drug Production and Capacity Analysis
• 4.2 Hemophilia A Drug Revenue Analysis
• 4.3 Hemophilia A Drug Price Analysis
• 4.4 Market Concentration Degree

5 Hemophilia A Drug Regional Market Analysis

• 5.1 Hemophilia A Drug Production by Regions
  • 5.1.1 Global Hemophilia A Drug Production by Regions
  • 5.1.2 Global Hemophilia A Drug Revenue by Regions
• 5.2 Hemophilia A Drug Consumption by Regions
• 5.3 North America Hemophilia A Drug Market Analysis
  • 5.3.1 North America Hemophilia A Drug Production
  • 5.3.2 North America Hemophilia A Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Hemophilia A Drug Import and Export
• 5.4 Europe Hemophilia A Drug Market Analysis
  • 5.4.1 Europe Hemophilia A Drug Production
  • 5.4.2 Europe Hemophilia A Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Hemophilia A Drug Import and Export
• 5.5 China Hemophilia A Drug Market Analysis
  • 5.5.1 China Hemophilia A Drug Production
  • 5.5.2 China Hemophilia A Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Hemophilia A Drug Import and Export
• 5.6 Japan Hemophilia A Drug Market Analysis
  • 5.6.1 Japan Hemophilia A Drug Production
  • 5.6.2 Japan Hemophilia A Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Hemophilia A Drug Import and Export
• 5.7 Southeast Asia Hemophilia A Drug Market Analysis
  • 5.7.1 Southeast Asia Hemophilia A Drug Production
  • 5.7.2 Southeast Asia Hemophilia A Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Hemophilia A Drug Import and Export
• 5.8 India Hemophilia A Drug Market Analysis
  • 5.8.1 India Hemophilia A Drug Production
  • 5.8.2 India Hemophilia A Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Hemophilia A Drug Import and Export

6 Hemophilia A Drug Segment Market Analysis (by Type)

• 6.1 Global Hemophilia A Drug Production by Type
• 6.2 Global Hemophilia A Drug Revenue by Type
• 6.3 Hemophilia A Drug Price by Type

7 Hemophilia A Drug Segment Market Analysis (by Application)

• 7.1 Global Hemophilia A Drug Consumption by Application
• 7.2 Global Hemophilia A Drug Consumption Market Share by Application (2014-2019)

8 Hemophilia A Drug Major Manufacturers Analysis

• 8.1 Bayer AG
  • 8.1.1 Bayer AG Hemophilia A Drug Production Sites and Area Served
  • 8.1.2 Bayer AG Product Introduction, Application and Specification
  • 8.1.3 Bayer AG Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 BioMarin Pharmaceutical Inc
  • 8.2.1 BioMarin Pharmaceutical Inc Hemophilia A Drug Production Sites and Area Served
  • 8.2.2 BioMarin Pharmaceutical Inc Product Introduction, Application and Specification
  • 8.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bioverativ Inc
  • 8.3.1 Bioverativ Inc Hemophilia A Drug Production Sites and Area Served
  • 8.3.2 Bioverativ Inc Product Introduction, Application and Specification
  • 8.3.3 Bioverativ Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Catalyst Biosciences Inc
  • 8.4.1 Catalyst Biosciences Inc Hemophilia A Drug Production Sites and Area Served
  • 8.4.2 Catalyst Biosciences Inc Product Introduction, Application and Specification
  • 8.4.3 Catalyst Biosciences Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Chugai Pharmaceutical Co Ltd
  • 8.5.1 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Sites and Area Served
  • 8.5.2 Chugai Pharmaceutical Co Ltd Product Introduction, Application and Specification
  • 8.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 CSL Ltd
  • 8.6.1 CSL Ltd Hemophilia A Drug Production Sites and Area Served
  • 8.6.2 CSL Ltd Product Introduction, Application and Specification
  • 8.6.3 CSL Ltd Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 DBV Technologies SA
  • 8.7.1 DBV Technologies SA Hemophilia A Drug Production Sites and Area Served
  • 8.7.2 DBV Technologies SA Product Introduction, Application and Specification
  • 8.7.3 DBV Technologies SA Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Dimension Therapeutics Inc
  • 8.8.1 Dimension Therapeutics Inc Hemophilia A Drug Production Sites and Area Served
  • 8.8.2 Dimension Therapeutics Inc Product Introduction, Application and Specification
  • 8.8.3 Dimension Therapeutics Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 EpiVax Inc
  • 8.9.1 EpiVax Inc Hemophilia A Drug Production Sites and Area Served
  • 8.9.2 EpiVax Inc Product Introduction, Application and Specification
  • 8.9.3 EpiVax Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Expression Therapeutics LLC
  • 8.10.1 Expression Therapeutics LLC Hemophilia A Drug Production Sites and Area Served
  • 8.10.2 Expression Therapeutics LLC Product Introduction, Application and Specification
  • 8.10.3 Expression Therapeutics LLC Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Green Cross Corp
• 8.12 Idogen AB
• 8.13 Immusoft Corp
• 8.14 LFB SA
• 8.15 mAbxience SA

9 Development Trend of Analysis of Hemophilia A Drug Market

• 9.1 Global Hemophilia A Drug Market Trend Analysis
  • 9.1.1 Global Hemophilia A Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Hemophilia A Drug Regional Market Trend
  • 9.2.1 North America Hemophilia A Drug Forecast 2019-2025
  • 9.2.2 Europe Hemophilia A Drug Forecast 2019-2025
  • 9.2.3 China Hemophilia A Drug Forecast 2019-2025
  • 9.2.4 Japan Hemophilia A Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Hemophilia A Drug Forecast 2019-2025
  • 9.2.6 India Hemophilia A Drug Forecast 2019-2025
• 9.3 Hemophilia A Drug Market Trend (Product Type)
• 9.4 Hemophilia A Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Hemophilia A Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List